DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.5681
+0.0231 (4.24%)
Jul 30, 2025, 9:43 AM - Market open
DarioHealth Stock Forecast
Stock Price Forecast
The 2 analysts that cover DarioHealth stock have a consensus rating of "Strong Buy" and an average price target of $2.5, which forecasts a 340.06% increase in the stock price over the next year. The lowest target is $2 and the highest is $3.
Price Target: $2.5 (+340.06%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 19, 2025.
Analyst Ratings
The average analyst rating for DarioHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Litchfield Hills | Litchfield Hills | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +428.08% | May 19, 2025 |
| Stifel | Stifel | Strong Buy Maintains $3.5 → $2 | Strong Buy | Maintains | $3.5 → $2 | +252.05% | Mar 11, 2025 |
| Stifel | Stifel | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +604.10% | Apr 1, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $5.45 → $4.1 | Strong Buy | Maintains | $5.45 → $4.1 | +621.70% | Aug 11, 2023 |
| Stifel | Stifel | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +956.15% | Jul 25, 2023 |
Financial Forecast
Revenue This Year
32.68M
from 27.04M
Increased by 20.85%
Revenue Next Year
38.27M
from 32.68M
Increased by 17.09%
EPS This Year
-0.87
from -0.61
EPS Next Year
-0.86
from -0.87
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 37.6M | 40.9M | 48.5M | ||
| Avg | 32.7M | 38.3M | 47.1M | ||
| Low | 28.1M | 35.4M | 45.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 39.2% | 25.1% | 26.8% | ||
| Avg | 20.9% | 17.1% | 23.2% | ||
| Low | 3.8% | 8.3% | 18.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.55 | -0.70 | -1.21 | ||
| Avg | -0.87 | -0.86 | -1.17 | ||
| Low | -1.17 | -1.00 | -1.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.